DETECTION ENABLED NANOTECHNOLOGY
NanoBurst™ is a test that uses a novel combination of DNA and lipid nanotechnology to produce an optical readout if a patient is positive for a target disease.
PORTAL 1™
Using first principles to design a bio-secure non-lateral flow based medical device. Intuitive, user-friendly and non-invasive. It’s point-of-care testing reimagined.
HUMAN-CENTERED DESIGN
Our goal is to create a testing experience that is convenient, accurate, and easy to use for both patients and healthcare providers. A human-centered design approach ensures that our test is not only effective but also accessible and user friendly. We believe that this will improve the overall testing experience and ultimately lead to better healthcare outcomes.
COMPLEXITY, REDUCED
Our device is compact and lightweight, making it easy to use in a variety of settings. We have eliminated the need for bulky hardware and streamlined the testing process, allowing users to quickly and easily obtain results. This eliminates the need for extensive training and makes our device accessible to a wider range of users.
ADAPTIVE GATEWAY™
We’ve developed an app so that each patient's test result can be quantified at the point-of-care and data be safely communicated to make reliable care decisions.
MACHINE LEARNING
Gateway improve over time. As more data is collected, our algorithm becomes more accurate and precise, allowing for better detection and monitoring of diseases. Providing the potential to greatly improve the accuracy and speed of disease diagnosis and monitoring.
SEAMLESS INTEGRATION
Design is focused around being user-friendly and seamless interface. Gateway can integrate effortlessly into existing clinical workflows - this means that healthcare providers can continue to use the tools and systems they are familiar with, without the need for extensive training or disruptions to their daily routine.